Monte Rosa TherapeuticsGLUE
那斯達克 · USD
18.80
-0.35
(-1.83%)
收盤 05/02 03:59 (UTC+8)
盤後
18.50
18.50
(-1.60%)
05/02 03:59 (UTC+8)
Monte Rosa TherapeuticsGLUE
18.80
-0.35
(-1.83%)
財務數據
損益表
- -
- -
- 0.01
- 0.05
- 0.09
- 0.61
- 0.85
- 0.23
- 0.13
- 0.03
- -
- -
- -
- 341.26
- 96.29
- 558.06
- 40.04
- -72.69
- -44.95
- -78.22
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 2,781 | 12,768 | 23,194 | 84,929 | 60,647 | 9,216 | 4,695 | 1,064 | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 2,781 | 12,768 | 23,194 | 84,929 | 60,647 | 9,216 | 4,695 | 1,064 | - | - |
營業費用 | 52,496 | 45,743 | 38,748 | - | - | - | - | 36,011 | 34,863 | 36,968 |
研發費用 | 41,979 | 36,678 | 30,653 | 32,190 | 38,866 | 27,616 | 28,055 | 27,026 | 27,135 | 28,306 |
推銷及管理費用 | 10,517 | 9,065 | 8,095 | 8,703 | 8,777 | 8,127 | 9,282 | 8,985 | 7,728 | 8,662 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -49,715 | -32,975 | -15,554 | 44,036 | 13,004 | -26,527 | -32,642 | -34,947 | -34,863 | -36,968 |
其他收入及費用 | 3,639 | 2,717 | 4,458 | 3,671 | 2,597 | 2,739 | 2,584 | 3,062 | 1,589 | 2,254 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -46,076 | -30,258 | -11,096 | 47,707 | 15,601 | -23,788 | -30,058 | -31,885 | -33,274 | -34,714 |
所得稅 | 59 | -3,177 | 1,199 | 822 | 2,164 | 71 | 252 | 83 | -22 | 170 |
稅後純益 | -46,135 | -27,081 | -12,295 | 46,885 | 13,437 | -23,859 | -30,310 | -31,968 | -33,252 | -34,884 |
基本每股稅後盈餘(元) | -0.70 | -0.44 | -0.20 | 0.57 | 0.22 | -0.29 | -0.43 | -0.53 | -0.58 | -0.70 |
稀釋每股稅後盈餘(元) | -0.55 | -0.33 | -0.15 | 0.57 | 0.23 | -0.26 | -0.42 | -0.53 | -0.57 | -0.70 |
基本平均股數(千股) | 65543.00 | 61790.00 | 61717.00 | 82148.00 | 61507.00 | 82011.00 | 71233.00 | 60156.00 | 56927.00 | 49814.00 |
稀釋平均股數(千股) | 65543.00 | 61790.00 | 61717.00 | 82956.00 | 61507.00 | 82011.00 | 71233.00 | 60156.00 | 56927.00 | 49814.00 |
還原基本每股稅後盈餘(元) | -0.70 | -0.44 | -0.20 | 0.57 | 0.22 | -0.29 | -0.43 | -0.53 | -0.58 | -0.70 |
還原稀釋每股稅後盈餘(元) | -0.55 | -0.33 | -0.15 | 0.57 | 0.23 | -0.26 | -0.42 | -0.53 | -0.57 | -0.70 |
還原基本平均股數(千股) | 65,543 | 61,790 | 61,717 | 82,148 | 61,507 | 82,011 | 71,233 | 60,156 | 56,927 | 49,814 |
還原稀釋平均股數(千股) | 65,543 | 61,790 | 61,717 | 82,956 | 61,507 | 82,011 | 71,233 | 60,156 | 56,927 | 49,814 |
EBITDA(千元) | -43,901 | -28,629 | -9,708 | 48,726 | 16,966 | -22,774 | -29,092 | -30,057 | -32,165 | -33,377 |